RT Book, Section
A1 Murri, PharmD, MBA, Nelda
A2 Brunton, Laurence L.
A2 Chabner, Bruce A.
A2 Knollmann, Björn C.
SR Print(0)
ID 1142353981
T1 The Goodman & Gilman Year in Review: New and Noteworthy FDA Approvals
T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 12e
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 9780071624428
LK accessbiomedicalscience.mhmedical.com/content.aspx?aid=1142353981
RD 2021/01/21
AB In  2016  the  U.S.  Food  and  Drug  Administration  (FDA)  approved  22  new  drugs  and  granted  32  noteworthy  biologic  licenses.  Among  the  22  new  drugs  are: